Ninety One (UK)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.5M Buy
337,425
+8,176
+2% +$2.26M 0.17% 92
2026
Q1
$97.2M Sell
329,249
-16,507
-5% -$4.9M 0.23% 82
2025
Q4
$94.4M Sell
345,756
-76
-0% -$20.7K 0.2% 77
2025
Q3
$93.4M Buy
345,832
+16,256
+5% +$4.42M 0.2% 80
2025
Q2
$90.8M Buy
329,576
+84,602
+35% +$23M 0.21% 75
2025
Q1
$65M Sell
244,974
-12,742
-5% -$3.14M 0.18% 83
2024
Q4
$59.8M Sell
257,716
-19,702
-7% -$4.53M 0.16% 84
2024
Q3
$61.2M Buy
277,418
+84,360
+44% +$17.5M 0.16% 90
2024
Q2
$38M Sell
193,058
-5,506
-3% -$1.14M 0.1% 111
2024
Q1
$42.7M Sell
198,564
-13,804
-7% -$2.9M 0.12% 105
2023
Q4
$44.7M Sell
212,368
-7,904
-4% -$1.69M 0.13% 94
2023
Q3
$44.1M Sell
220,272
-5,788
-3% -$1.15M 0.14% 96
2023
Q2
$41.9M Hold
226,060
0.12% 106
2023
Q1
$43.3M Buy
226,060
+3,825
+2% +$692K 0.13% 104
2022
Q4
$37.4M Buy
222,235
+6,648
+3% +$1.16M 0.12% 111
2022
Q3
$38.2M Buy
215,587
+10,379
+5% +$2.05M 0.13% 110
2022
Q2
$42M Sell
205,208
-19,294
-9% -$4.09M 0.12% 109
2022
Q1
$53.4M Sell
224,502
-120,598
-35% -$28.3M 0.14% 113
2021
Q4
$78.8M Sell
345,100
-131,667
-28% -$29M 0.19% 102
2021
Q3
$92.2M Buy
476,767
+114,449
+32% +$23.2M 0.24% 97
2021
Q2
$77.1M Sell
362,318
-28,851
-7% -$6.09M 0.2% 107
2021
Q1
$79.9M Sell
391,169
-22,987
-6% -$4.53M 0.23% 106
2020
Q4
$75.4M Sell
414,156
-242,206
-37% -$41.2M 0.23% 104
2020
Q3
$110M Sell
656,362
-14,029
-2% -$2.36M 0.4% 63
2020
Q2
$109M Buy
670,391
+203,546
+44% +$36.5M 0.39% 64
2020
Q1
$80.7M Sell
466,845
-25,002
-5% -$4.98M 0.34% 67
2019
Q4
$98.7M Sell
491,847
-25,103
-5% -$5.15M 0.33% 77
2019
Q3
$109M Sell
516,950
-64,220
-11% -$13.4M 0.43% 66
2019
Q2
$113M Buy
581,170
+9,238
+2% +$1.7M 0.43% 62
2019
Q1
$94.1M Buy
571,932
+33,600
+6% +$5.94M 0.37% 71
2018
Q4
$101M Sell
538,332
-43,996
-8% -$8.12M 0.44% 65
2018
Q3
$99.1M Buy
582,328
+289,093
+99% +$48.7M 0.37% 78
2018
Q2
$48.1M Sell
293,235
-4,397
-1% -$718K 0.24% 94
2018
Q1
$48.1M Sell
297,632
-252,344
-46% -$40.2M 0.26% 92
2017
Q4
$80.3M Sell
549,976
-95,399
-15% -$13.6M 0.33% 80
2017
Q3
$87.6M Sell
645,375
-1,816,241
-74% -$229M 0.38% 74
2017
Q2
$308M Sell
2,461,616
-4,840
-0.2% -$579K 1.47% 14
2017
Q1
$293M Sell
2,466,456
-22,895
-0.9% -$2.75M 1.45% 13
2016
Q4
$287M Sell
2,489,351
-30,421
-1% -$3.39M 1.5% 12
2016
Q3
$263M Buy
2,519,772
+780,686
+45% +$81.5M 1.28% 20
2016
Q2
$169M Buy
1,739,086
+169,272
+11% +$16M 0.88% 42
2016
Q1
$151M Buy
1,569,814
+1,540,731
+5,298% +$140M 0.82% 44
2015
Q4
$2.63M Buy
29,083
+423
+1% +$39.8K 0.02% 238
2015
Q3
$2.66M Buy
+28,660
New +$2.72M 0.02% 225

Other funds holding CME

Ninety One (UK)'s CME Position: Q2 2026 in Review

Ninety One (UK) increased its CME Group (CME) stake by 2.5% in Q2 2026, buying an estimated $2.26M and bringing the position to 337,425 shares worth $74.5M. The position accounts for 0.17% of the portfolio, ranked #92.

Ninety One (UK) first reported a position in CME in Q3 2015 and has held it in 44 quarters since. The position peaked at $308M in Q2 2017. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Ninety One (UK) held 337,425 shares of CME Group worth $74.5M as of Q2 2026.
  • Ninety One (UK) bought 8,176 CME Group shares in Q2 2026, an estimated $2.26M.
  • CME Group made up 0.17% of Ninety One (UK)'s portfolio in Q2 2026, its #92 holding.
  • Ninety One (UK) first reported a position in CME Group in Q3 2015 and has held it in 44 quarters since.
  • Ninety One (UK)'s CME Group position peaked at $308M in Q2 2017.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.